106 related articles for article (PubMed ID: 18182248)
21. Hop bitter acids efficiently block inflammation independent of GRalpha, PPARalpha, or PPARgamma.
Van Cleemput M; Heyerick A; Libert C; Swerts K; Philippé J; De Keukeleire D; Haegeman G; De Bosscher K
Mol Nutr Food Res; 2009 Sep; 53(9):1143-55. PubMed ID: 19655312
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
Xiao J; Leung JC; Chan LY; Guo H; Lai KN
Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534
[TBL] [Abstract][Full Text] [Related]
23. Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.
Liu Y; Shi J; Lu J; Meng G; Zhu H; Hou Y; Yin Y; Zhao S; Ding B
Innate Immun; 2009 Jun; 15(3):169-78. PubMed ID: 19474210
[TBL] [Abstract][Full Text] [Related]
24. Oxidised lipids present in ascitic fluid interfere with the regulation of the macrophages during acute pancreatitis, promoting an exacerbation of the inflammatory response.
Gutierrez PT; Folch-Puy E; Bulbena O; Closa D
Gut; 2008 May; 57(5):642-8. PubMed ID: 18203805
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor-alpha modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice.
Riccardi L; Mazzon E; Bruscoli S; Esposito E; Crisafulli C; Di Paola R; Caminiti R; Riccardi C; Cuzzocrea S
Shock; 2009 Mar; 31(3):308-16. PubMed ID: 18665053
[TBL] [Abstract][Full Text] [Related]
26. PPAR and Pain.
Maeda T; Kishioka S
Int Rev Neurobiol; 2009; 85():165-77. PubMed ID: 19607969
[TBL] [Abstract][Full Text] [Related]
27. Proinflammatory cytokine and ligands modulate cardiac peroxisome proliferator-activated receptors.
Lee TI; Kao YH; Chen YC; Chen YJ
Eur J Clin Invest; 2009 Jan; 39(1):23-30. PubMed ID: 19067734
[TBL] [Abstract][Full Text] [Related]
28. Genomic analysis of sulfasalazine effect in experimental colitis is consistent primarily with the modulation of NF-kappaB but not PPAR-gamma signaling.
Martínez-Augustin O; López-Posadas R; González R; Suárez MD; Zarzuelo A; Sánchez de Medina F
Pharmacogenet Genomics; 2009 May; 19(5):363-72. PubMed ID: 19365232
[TBL] [Abstract][Full Text] [Related]
29. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
[TBL] [Abstract][Full Text] [Related]
30. Immune-compromised state in the rat pancreas after chronic alcohol exposure: the role of peroxisome proliferator-activated receptor gamma.
Fortunato F; Berger I; Gross ML; Rieger P; Buechler MW; Werner J
J Pathol; 2007 Dec; 213(4):441-52. PubMed ID: 17935147
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K
Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonists down-regulate alpha2-macroglobulin expression by a PPARalpha-dependent mechanism.
González MC; Corton JC; Cattley RC; Herrera E; Bocos C
Biochimie; 2009 Aug; 91(8):1029-35. PubMed ID: 19497347
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor gamma agonist reduces the severity of post-ERCP pancreatitis in rats.
Folch-Puy E; Granell S; Iovanna JL; Barthet M; Closa D
World J Gastroenterol; 2006 Oct; 12(40):6458-63. PubMed ID: 17072978
[TBL] [Abstract][Full Text] [Related]
34. The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis.
Jeon EJ; Lee SK; Park YS; Kim DH; Yum JH; Park CS
Otolaryngol Head Neck Surg; 2008 Jul; 139(1):124-30. PubMed ID: 18585574
[TBL] [Abstract][Full Text] [Related]
35. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.
Bernardo A; Bianchi D; Magnaghi V; Minghetti L
J Neuropathol Exp Neurol; 2009 Jul; 68(7):797-808. PubMed ID: 19535992
[TBL] [Abstract][Full Text] [Related]
37. Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways.
Mei CL; He P; Cheng B; Liu W; Wang YF; Wan JJ
Cell Biol Int; 2009 Mar; 33(3):301-8. PubMed ID: 19114110
[TBL] [Abstract][Full Text] [Related]
38. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis.
Staumont-Sallé D; Abboud G; Brénuchon C; Kanda A; Roumier T; Lavogiez C; Fleury S; Rémy P; Papin JP; Bertrand-Michel J; Tercé F; Staels B; Delaporte E; Capron M; Dombrowicz D
J Allergy Clin Immunol; 2008 Apr; 121(4):962-8.e6. PubMed ID: 18249437
[TBL] [Abstract][Full Text] [Related]
40. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
